Results from pooled Phase III studies of ulipristal acetate for emergency contraception

作者: Caroline Moreau , James Trussell

DOI: 10.1016/J.CONTRACEPTION.2012.05.012

关键词: Lost to follow-upFamily planningPregnancy rateEmergency contraceptionGynecologyBody mass indexUlipristal acetatePopulationMedicinePregnancy

摘要: Abstract Background Ulipristal acetate (UPA) is a new effective option to prevent unintended pregnancies up 5 days after unprotected intercourse. We used pooled data from two Phase III studies refine our understanding of the efficacy UPA by time intercourse and effects other factors on pregnancy rates. Study Design Data were create larger analysis population. Analyses performed first participation 2183 women. Results A total 41 women became pregnant despite use UPA, yielding an overall proportion 1.9% (1.3%–2.5%). Proportions higher among those with further acts in same cycle obese These varied 1.3% (0.9%–2.0%) nonobese who had no (n= 1704) 8.3% (0.2%–38.5%) subsequent (n= 12). Conclusions safe preventing Its effectiveness lower have

参考文章(12)
H.B. Croxatto, V. Brache, M. Pavez, L. Cochon, M.L. Forcelledo, F. Alvarez, R. Massai, A. Faundes, A.M. Salvatierra, Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation. Contraception. ,vol. 70, pp. 442- 450 ,(2004) , 10.1016/J.CONTRACEPTION.2004.05.007
Pamela Stratton, Eric D. Levens, Beth Hartog, Johann Piquion, Qingxiang Wei, Maria Merino, Lynnette K. Nieman, Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914 Fertility and Sterility. ,vol. 93, pp. 2035- 2041 ,(2010) , 10.1016/J.FERTNSTERT.2008.12.057
Marta Durand, Markku Seppala, Ma. del Carmen Cravioto, Hannu Koistinen, Riitta Koistinen, José González-Macedo, Fernando Larrea, Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle Contraception. ,vol. 71, pp. 451- 457 ,(2005) , 10.1016/J.CONTRACEPTION.2005.01.003
Paul Fine, Henri Mathé, Savita Ginde, Vanessa Cullins, Johanna Morfesis, Erin Gainer, Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. Obstetrics & Gynecology. ,vol. 115, pp. 257- 263 ,(2010) , 10.1097/AOG.0B013E3181C8E2AA
Elizabeth Raymond, Douglas Taylor, James Trussell, Markus J. Steiner, Minimum effectiveness of the levonorgestrel regimen of emergency contraception Contraception. ,vol. 69, pp. 79- 81 ,(2004) , 10.1016/J.CONTRACEPTION.2003.09.013
K. Cleland, H. Zhu, N. Goldstuck, L. Cheng, J. Trussell, The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience Human Reproduction. ,vol. 27, pp. 1994- 2000 ,(2012) , 10.1093/HUMREP/DES140
Josiane A.A. do Nascimento, Markku Seppala, Antero Perdigão, Ximena Espejo-Arce, Maria José Munuce, Laura Hautala, Riitta Koistinen, Liliana Andrade, Luis Bahamondes, In vivo assessment of the human sperm acrosome reaction and the expression of glycodelin-A in human endometrium after levonorgestrel-emergency contraceptive pill administration Human Reproduction. ,vol. 22, pp. 2190- 2195 ,(2007) , 10.1093/HUMREP/DEM119
V. Brache, L. Cochon, C. Jesam, R. Maldonado, A. M. Salvatierra, D. P. Levy, E. Gainer, H. B. Croxatto, Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture Human Reproduction. ,vol. 25, pp. 2256- 2263 ,(2010) , 10.1093/HUMREP/DEQ157
Anna F Glasier, Sharon T Cameron, Paul M Fine, Susan JS Logan, William Casale, Jennifer Van Horn, Laszlo Sogor, Diana L Blithe, Bruno Scherrer, Henri Mathe, Amelie Jaspart, Andre Ulmann, Erin Gainer, Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis The Lancet. ,vol. 375, pp. 555- 562 ,(2010) , 10.1016/S0140-6736(10)60101-8